Significance of soluble TNF receptor-I in acute-type fulminant hepatitis

American Journal of Gastroenterology

Volumn 95, Issue 8, 2000, Pages 2040-2046

  Tokushige, Katsutoshi ^a   Yamaguchi, Naoko ^b   Ikeda, Ikuo ^b   Hashimoto, Etsuko ^b   Yamauchi, Katsumi ^b   Hayashi, Naoaki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS; HUMAN; LIVER DISEASE; LIVER INJURY; LIVER NECROSIS; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD95; FAS LIGAND PROTEIN; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033892895     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)01062-5     Document Type: Article

References (30)

1. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure
2. Tumor necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection
3. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure
4. Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant failure and acute hepatitis
5. Concanavalin A-induced liver cell damage. Activation of intracellular pathway triggered by tumor necrosis factor in mice
6. Unravelling function in the TNF ligand and receptor families
7. Interleukin-6 (IL-6) as an anti-inflammatory cytokine. Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
8. Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans
9. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms
10. Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor and intedeukin-1 receptor antagonist
11. Circulating tumor necrosis factor (TNF) alpha, soluble TNF receptors and interleukin-6 in human subacute endocarditis
12. Tumor necrosis factor receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vivo and in vivo
13. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia
14. Plasma inhibitory activity against tumor necosis factor in fulminant hepatic failure
15. Serum levels and in situ expression of TNF-α and TNF-α binding proteins in inflammatory liver diseases
16. Lethal effect of anti-Fas antibody in mice
17. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
18. A possible role of Fas mediated apoptosis in human fulminant hepatitis
19. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicenter study
20. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis
21. Detection of hepatitis C virus by two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region
22. Early indica tors of prognosis in fulminant hepatic failure
23. Discrimination of two different clinical entities, acute-type and subacute-type, human fulminant hepatitis by peripheral blood lymphocyte subsets
24. Protection from Fas-mediated apotosis by a soluble form of the Fas molecule
25. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
26. p75(NTR). A receptor after all
27. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
28. TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
29. An essential role for NF-κB in preventing TNF-α-induced cell death
30. Hepatic expression of type A and type B receptors for tumor necrosis factor